Essays about: "pharmaceutical europe market"
Showing result 6 - 10 of 13 essays containing the words pharmaceutical europe market.
-
6. A Skinny Label - The intersection of EU competition law and patent law, and the abuse of dominance by the enforcement of second medical use patents
University essay from Lunds universitet/Juridiska institutionenAbstract : EU competition law is the safeguard of the functioning of the internal market, and not many fields of law other than patent law can delimit the scope of competition law. A patent’s value is based upon an exclusive right to the invention and product as protected by the patent. READ MORE
-
7. Alternative legal incentives for antibiotic research and development : The role and function of legal mechanisms
University essay from Uppsala universitet/Juridiska institutionenAbstract : In Europe there are 25 000 deaths per year as a result of antimicrobial resistance and in the world the estimated annual number of deaths is 700 000. By 2050, it has been predicted that 10 million people per year could die from being resistant to antibiotic compounds. READ MORE
-
8. EU Commitments in Pharmaceutical Mergers & Acquisitions - Merging Parties' Guidelines on the Notification of Complex Concentrations. Towards a Fairer System
University essay from Lunds universitet/Juridiska institutionenAbstract : Commitments under the EU merger control have been used as the tool to balance the preservation of fierce competition in the single market and the positive impact of M&A activity both in Europe and worldwide. Infrequently, the complex competitive analysis of concentrations results in the finding of serious doubts as to the compatibility of the transaction with the common market. READ MORE
-
9. Paying for Delay or Something Else?--The Potential Anticompetitive Effect of Reverse Payment Patent Settlements in the Pharmaceutical Industry under article 101 TFEU
University essay from Lunds universitet/Juridiska institutionenAbstract : This thesis discusses the recent hot topic in the intersection of IP law and competition law; “pay-for-delay” agreements in the pharmaceutical industry. Such agreements arise in patent disputes where originator manufacturers (‘Originators’) claim patent infringement by the generic manufactures (‘Generics’). READ MORE
-
10. Parallel Trade in the European Union: Competition Law Aspects
University essay from Lunds universitet/Juridiska institutionenAbstract : This thesis is devoted to competition law aspects of parallel trade regulation in the European Union. The long line of case law of the European Court of Justice and the European Commission reflects the changes of the approaches towards the problem of parallel trade restrictions, where the very first cases establish the fundamental framework and policies for development of the internal market through the free movement of goods, and the most recent jurisprudence aims to review those approaches in the light of the rule of reason and efficiency gains policy with the focus on welfare of final consumers. READ MORE
